Kindly MD Inc
NASDAQ:KDLY
Profitability Summary
Kindly MD Inc's profitability score is 22/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Score
Score
Margins
Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.
Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Earnings Waterfall
Kindly MD Inc
Revenue
|
2.5m
USD
|
Cost of Revenue
|
-83k
USD
|
Gross Profit
|
2.4m
USD
|
Operating Expenses
|
-6.6m
USD
|
Operating Income
|
-4.2m
USD
|
Other Expenses
|
-183k
USD
|
Net Income
|
-4.4m
USD
|
Margins Comparison
Kindly MD Inc Competitors
Country | Company | Market Cap |
Gross Margin |
Operating Margin |
Net Margin |
||
---|---|---|---|---|---|---|---|
US |
K
|
Kindly MD Inc
NASDAQ:KDLY
|
141.3m USD |
97%
|
-170%
|
-177%
|
|
US |
C
|
Cigna Group
XMUN:CGN
|
73.6B EUR |
10%
|
4%
|
2%
|
|
US |
![]() |
Cigna Corp
NYSE:CI
|
86.3B USD |
10%
|
4%
|
2%
|
|
US |
![]() |
CVS Health Corp
NYSE:CVS
|
85.1B USD |
14%
|
3%
|
1%
|
|
DE |
![]() |
Fresenius Medical Care AG
XMUN:FME
|
27.9B EUR |
24%
|
7%
|
3%
|
|
DE |
![]() |
Fresenius SE & Co KGaA
XETRA:FRE
|
23.8B EUR |
24%
|
9%
|
2%
|
|
US |
![]() |
Laboratory Corporation of America Holdings
NYSE:LH
|
21.9B USD |
28%
|
9%
|
6%
|
|
US |
![]() |
Quest Diagnostics Inc
NYSE:DGX
|
19.8B USD |
33%
|
14%
|
9%
|
|
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
13.9B EUR |
24%
|
7%
|
3%
|
|
US |
![]() |
DaVita Inc
NYSE:DVA
|
11B USD |
32%
|
15%
|
7%
|
|
US |
![]() |
Hims & Hers Health Inc
NYSE:HIMS
|
10.7B USD |
77%
|
6%
|
9%
|
Return on Capital
Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.
Mar 31, 2025 | -763.2% |
Dec 31, 2024 | -294.1% |
Sep 30, 2024 | -178.7% |
Jun 30, 2024 | -113% |
Mar 31, 2025 | -260.1% |
Dec 31, 2024 | -151.5% |
Sep 30, 2024 | -113.6% |
Jun 30, 2024 | -77.8% |
Mar 31, 2025 | -432.2% |
Dec 31, 2024 | -199.4% |
Sep 30, 2024 | -136.6% |
Jun 30, 2024 | -84.5% |
Mar 31, 2025 | -659.5% |
Dec 31, 2024 | -505.3% |
Sep 30, 2024 | -1 000.9% |
Jun 30, 2024 | -793% |
Return on Capital Comparison
Kindly MD Inc Competitors
Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
---|---|---|---|---|---|---|---|---|
US |
K
|
Kindly MD Inc
NASDAQ:KDLY
|
141.3m USD |
-763%
|
-260%
|
-432%
|
-659%
|
|
US |
C
|
Cigna Group
XMUN:CGN
|
73.6B EUR |
12%
|
3%
|
10%
|
6%
|
|
US |
![]() |
Cigna Corp
NYSE:CI
|
86.3B USD |
12%
|
3%
|
10%
|
6%
|
|
US |
![]() |
CVS Health Corp
NYSE:CVS
|
85.1B USD |
7%
|
2%
|
6%
|
4%
|
|
DE |
![]() |
Fresenius Medical Care AG
XMUN:FME
|
27.9B EUR |
4%
|
2%
|
5%
|
3%
|
|
DE |
![]() |
Fresenius SE & Co KGaA
XETRA:FRE
|
23.8B EUR |
2%
|
1%
|
5%
|
3%
|
|
US |
![]() |
Laboratory Corporation of America Holdings
NYSE:LH
|
21.9B USD |
9%
|
4%
|
8%
|
6%
|
|
US |
![]() |
Quest Diagnostics Inc
NYSE:DGX
|
19.8B USD |
13%
|
6%
|
11%
|
9%
|
|
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
13.9B EUR |
4%
|
2%
|
5%
|
3%
|
|
US |
![]() |
DaVita Inc
NYSE:DVA
|
11B USD |
261%
|
5%
|
13%
|
10%
|
|
US |
![]() |
Hims & Hers Health Inc
NYSE:HIMS
|
10.7B USD |
37%
|
25%
|
24%
|
48%
|
Free Cash Flow
Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.
If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.
Mar 31, 2025 | -3.7m |
Dec 31, 2024 | -3.1m |
Sep 30, 2024 | -2.4m |
Jun 30, 2024 | -1.3m |
Mar 31, 2025 | -563.9k |
Dec 31, 2024 | -401.6k |
Sep 30, 2024 | -13.3k |
Jun 30, 2024 | -11.2k |
Mar 31, 2025 | -4.3m |
Dec 31, 2024 | -3.5m |
Sep 30, 2024 | -2.4m |
Jun 30, 2024 | -1.3m |